Engineers Gate Manager’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Engineers Gate Manager’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,493	Closed	-$288K	–	2237
2020 Q4	$288K	Sell	16,493 -4,798	-23%	-$67.3K	0.01%	1322
2020 Q3	$249K	Buy	21,291 +2,980	+16%	+$39.5K	0.01%	1338
2020 Q2	$238K	Buy	18,311 +8,074	+79%	+$97K	0.01%	1344
2020 Q1	$95K	Buy	+10,237	New	+$143K	0.01%	1424
2019 Q1	–	Sell	-15,587	Closed	-$199K	–	1254
2018 Q4	$199K	Buy	15,587 +4,025	+35%	+$61K	0.02%	750
2018 Q3	$188K	Buy	+11,562	New	+$165K	0.01%	810

Engineers Gate Manager's OXFD Position: Q1 2021 in Review

Engineers Gate Manager sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 16,493 shares — an estimated $288K sold.

Engineers Gate Manager first reported a position in OXFD in Q3 2018 and held it in 6 quarters. The position peaked at $288K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Engineers Gate Manager reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Engineers Gate Manager sold 16,493 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $288K.
Engineers Gate Manager first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and held it in 6 quarters.
Engineers Gate Manager's Oxford Immunotec Global PLC Ordinary Shares position peaked at $288K in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Engineers Gate Manager's 13F filing for Q1 2021, filed 17 May 2021.